InvestorsHub Logo
Followers 39
Posts 6458
Boards Moderated 1
Alias Born 11/09/2019

Re: saigai post# 230

Sunday, 09/18/2022 12:03:54 PM

Sunday, September 18, 2022 12:03:54 PM

Post# of 255
Stock looks poised for an upward move. It would need to tripple to be valued at current cash and tangibles. Factor in the patents, nols, phase II test results, in play to be acquired, it's probably one of the best reward to risks plays in the small cap bio sector. I put a 3-6 buyout depending on the data released on results. I might be low on the buyout to??

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.